DOWNINGTOWN, Pa. (March 3, 2021) — ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced several members of its consulting leadership team members will be speaking at the 2021 PDA Annual Meeting on Advancing People, Connecting Data, and Evolving Manufacturing Technologies. Stephen E. Langille, Ph.D., Senior Microbiology Consultant at ValSource, Tiffany Baker, MBA, Consultant at ValSource, Amanda McFarland, MS, Senior Consultant at ValSource, Danica Brown, Consultant at ValSource, and Christopher J. Smalley, MBA, MS, Ph.D., Compounding Pharmacist Advisor at Valsource are each scheduled to speak at the conference at sessions that include Improving, Modernizing, Transforming – Process Validation Gets a (much needed) Upgrade and Modern Toolkits for Enhancing People Competency, Improving Data Integrity through Culture Metrics.
Baseman’s session will address the Use and Mis-Use of Aseptic Process Simulations for Aseptic Process Validation. McFarland is the moderator of that session, providing direction throughout the discussion. Dr. Langille’s presentation will focus on Campaign Promise: Points to Consider When Designing a Multi-Batch Aseptic Processing Campaign. Baker, McFarland, and Brown will participate in a panel discussion on Lessons Learned from QRM Practitioners. Dr. Smalley’s presentation will be on The Role of Quality Culture in Assuring Data Integrity.
The 2021 PDA Annual Meeting conference will highlight what’s in store for the future of pharmaceutical manufacturing. Specifically, examining how companies are developing new modalities and adapting to the current manufacturing environment through the modernization of aging facilities and the adoption of innovative approaches and processes. Each interactive session is designed for manufacturing leaders, technical experts/scientists, and early career professionals. To attend, register by March 14, 2021 at www.pda.org/conference/2021-pda-annual-meeting.
ValSource is the premier provider of consulting and advisory services for the biological, medical device, and pharmaceutical industries. The company specializes in program and project delivery including capital project execution, procurement, commissioning, qualification and validation, compliance, and quality risk management – serving clients as advisors, trusted consultants, and highly experienced program managers. Valsource is committed to helping projects get to a qualified and validated state with the most efficient solutions. To learn more, visit www.valsource.com.